Literature DB >> 15986630

Prevalence of antibodies to Trypanosoma cruzi in raccoons (Procyon lotor) from an urban area of northern Virginia.

Katie Hancock1, Anne M Zajac, Oscar J Pung, Francois Elvinger, Alexa C Rosypal, David S Lindsay.   

Abstract

Raccoons (Procyon lotor) are reservoir hosts for Trypanosoma cruzi. A 3-yr-long serological survey was conducted to determine the prevalence of antibodies to this zoonotic parasite in raccoons collected from Fairfax County, Virginia, a suburban/urban area outside Washington, D.C. Serum samples from 464 raccoons were examined for T. cruzi antibodies at a 1:40 dilution with an indirect fluorescent antibody test (IFAT) and Brazil strain T. cruzi amastigotes and trypomastigotes as antigen. A positive IFAT test was found in 154 (33%) of the 464 samples. The yearly prevalence was 49 of 132 (37%) in 2000; 19 of 120 (16%) in 2001; and 86 of 212 (41%) in 2002. Our study indicates that raccoons in this area of Virginia are frequently exposed to T. cruzi.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986630     DOI: 10.1645/GE-399R

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  10 in total

1.  Trypanosoma cruzi in non-human primates with a history of stillbirths: a retrospective study (Papio hamadryas spp.) and case report (Macaca fascicularis).

Authors:  Jessica L Grieves; Gene B Hubbard; Jeff T Williams; John L Vandeberg; Edward J Dick; Juan C López-Alvarenga; Natalia E Schlabritz-Loutsevitch
Journal:  J Med Primatol       Date:  2008-07-30       Impact factor: 0.667

2.  Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease.

Authors:  Walderez Ornelas Dutra; Cristiane Alves Silva Menezes; Fernanda Nobre Amaral Villani; Germano Carneiro da Costa; Alexandre Barcelos Morais da Silveira; Débora d'Avila Reis; Kenneth J Gollob
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

3.  Seroprevalence of Trypanosoma cruzi among eleven potential reservoir species from six states across the southern United States.

Authors:  Emily L Brown; Dawn M Roellig; Matthew E Gompper; Ryan J Monello; Krista M Wenning; Mourad W Gabriel; Michael J Yabsley
Journal:  Vector Borne Zoonotic Dis       Date:  2009-12-18       Impact factor: 2.133

Review 4.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

5.  Estimating contact process saturation in sylvatic transmission of Trypanosoma cruzi in the United States.

Authors:  Christopher Kribs-Zaleta
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

6.  Southern plains woodrats (Neotoma micropus) from southern Texas are important reservoirs of two genotypes of Trypanosoma cruzi and host of a putative novel Trypanosoma species.

Authors:  Roxanne A Charles; Sonia Kjos; Angela E Ellis; John C Barnes; Michael J Yabsley
Journal:  Vector Borne Zoonotic Dis       Date:  2012-11-05       Impact factor: 2.133

7.  Evaluation of the Chagas Stat-Pak assay for detection of Trypanosoma cruzi antibodies in wildlife reservoirs.

Authors:  Michael J Yabsley; Emily L Brown; Dawn M Roellig
Journal:  J Parasitol       Date:  2009-06       Impact factor: 1.276

Review 8.  Trypanosoma cruzi: adaptation to its vectors and its hosts.

Authors:  François Noireau; Patricio Diosque; Ana Maria Jansen
Journal:  Vet Res       Date:  2009-03-03       Impact factor: 3.683

9.  Toward an Ecological Framework for Assessing Reservoirs of Vector-Borne Pathogens: Wildlife Reservoirs of Trypanosoma cruzi across the Southern United States.

Authors:  Carolyn L Hodo; Sarah A Hamer
Journal:  ILAR J       Date:  2017-12-15

10.  Nationwide Exposure of U.S. Working Dogs to the Chagas Disease Parasite, Trypanosoma cruzi.

Authors:  Alyssa C Meyers; Julia C Purnell; Megan M Ellis; Lisa D Auckland; Marvin Meinders; Sarah A Hamer
Journal:  Am J Trop Med Hyg       Date:  2020-05       Impact factor: 2.345

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.